International journal of antimicrobial agents
-
Int. J. Antimicrob. Agents · Jun 2020
ReviewDrug repositioning is an alternative for the treatment of coronavirus COVID-19.
Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.